Title: FMph-Family Medicine – Pharmacology: Antibiotic Therapy; Drug-Drug Interactions; Cannabis Pharmacology
Faculty: Benjamin M. Kaplan, M.D., Joel Kravitz, M.D., F.A.C.E.P., F.R.C.P.S.C., Blair Weikert, M.D.
Original Release Date: July 1, 2020 Expiration Date: July 1, 2023
SPECIFIC OBJECTIVES FOR EACH TOPIC:
TOPIC 1: Update in Antibiotic Therapy.
Upon completion of this session, the participant should be able to: COMP
- Appraise the pharmacology and antibacterial spectrum of activity of the newer antibiotics.
- Assess the indications for use of newer agents based on sites of infection and susceptibility patterns and apply the appropriate drug recommendation to key clinical scenarios as per the IDSA guidelines.
- Relate the side effects, adverse reactions and important drug-drug interactions affiliated with each antibiotic.
TOPIC 2: Drug-Drug Interactions (DDIs).
Upon completion of this session, the participant should be able to: COMP, GL
- Assess the scope of the problem of drug-drug interactions as it pertains to both the outpatient and emergency settings.
- Explore interactions between prescription and non-prescription medications and review their treatments in the context of the Beers Criteria.
- Review common drug-drug interactions and their complications commonly seen in the emergency room
TOPIC 3 The Science Behind Cannabis Pharmacology.
Upon completion of this session, the participant should be able to: COMP, EBM
- Understand the central mechanism of action for the most common cannabinoids.
- Define and understand the role of the Endocannabinoid system.
- Describe the pharmacological effects on the human body through a system-based approach using evidence-based research.
- Discuss toxicity levels of THC and impact on overall health.
- Understand the mechanism behind tolerance and dependence.
- The receipt for any incentive-associated purchase will designate the value of the gift card separately from the cost of the learning activity.
- This incentive may have implications on your tax reporting obligations. Any reimbursed amount must be declared as personal income for tax purposes.